심장이식 치료 시장은 2024-2029년 1억 2,970만 달러 증가하고, 예측 기간 동안 3%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
세계의 심장이식 치료 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 심혈관 질환 및 심부전 유병률 증가, 다양한 제형의 약물 가용성, 심장이식 시 면역억제제에 대한 의존도 증가에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2025년 |
| 종료 연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비 2025년 |
2.8% |
| CAGR |
3% |
| 증가액 |
1억 2,970만 달러 |
이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.
이 보고서는 향후 몇 년동안 심장이식 치료 시장의 성장을 가속하는 주요 요인 중 하나로 심장이식 관련 국제 협력 관계의 확대를 꼽고 있습니다. 또한, 심장이식을 위한 기술의 출현, 심장이식에 대한 인식과 접근성 향상은 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 Technavio의 분석
- 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2024
- 시장 전망 2024-2029
제5장 시장 규모 실적
- 세계의 심장이식 치료 시장(2019-2023년)
- 약제 클래스별 부문 분석(2019-2023년)
- 유통 채널별 부문 분석(2019-2023년)
- 유형별 부문 분석(2019-2023년)
- 적응증별 부문 분석(2019-2023년)
- 지역별 부문 분석(2019-2023년)
- 국가별 부문 분석(2019-2023년)
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 약제 클래스별
- 시장 부문
- 비교 : 약제 클래스별
- 면역억제제 : 시장 규모와 예측(2024-2029년)
- 항감염제 : 시장 규모와 예측(2024-2029년)
- 진통제 : 시장 규모와 예측(2024-2029년)
- 기타 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 약제 클래스별
제9장 시장 세분화 : 유통 채널별
- 시장 부문
- 비교 : 유통 채널별
- 병원 약국 : 시장 규모와 예측(2024-2029년)
- 소매 약국 : 시장 규모와 예측(2024-2029년)
- 온라인 약국 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 유통 채널별
제10장 시장 세분화 : 유형별
- 시장 부문
- 비교 : 유형별
- 좌심실 보조 장치(LVAD) : 시장 규모와 예측(2024-2029년)
- 심장이식 : 시장 규모와 예측(2024-2029년)
- 이식형 심장 제세동기(ICD) : 시장 규모와 예측(2024-2029년)
- 에크모(ECMO) : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 유형별
제11장 시장 세분화 : 적응증별
- 시장 부문
- 비교 : 적응증별
- 허혈성 심질환(IHD) : 시장 규모와 예측(2024-2029년)
- 확장형 심근증(DCM) : 시장 규모와 예측(2024-2029년)
- 판막증(VHD) : 시장 규모와 예측(2024-2029년)
- 비대형 심근증(HCM) : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 적응증별
제12장 고객 상황
제13장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측(2024-2029년)
- 유럽 : 시장 규모와 예측(2024-2029년)
- 아시아 : 시장 규모와 예측(2024-2029년)
- 세계 기타 지역 : 시장 규모와 예측(2024-2029년)
- 미국 : 시장 규모와 예측(2024-2029년)
- 독일 : 시장 규모와 예측(2024-2029년)
- 캐나다 : 시장 규모와 예측(2024-2029년)
- 프랑스 : 시장 규모와 예측(2024-2029년)
- 일본 : 시장 규모와 예측(2024-2029년)
- 영국 : 시장 규모와 예측(2024-2029년)
- 인도 : 시장 규모와 예측(2024-2029년)
- 중국 : 시장 규모와 예측(2024-2029년)
- 한국 : 시장 규모와 예측(2024-2029년)
- 이탈리아 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 지역 상황별
제14장 성장 촉진요인, 과제, 기회 및 성장 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회와 성장 억제요인
제15장 경쟁 구도
제16장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- AbbVie Inc.
- Astellas Pharma Inc.
- Biocon Ltd.
- Dr Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.
- LEO Pharma AS
- Lupin Ltd.
- Novartis AG
- Panacea Biotec Ltd.
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
제17장 부록
LSH
The heart transplantation therapeutics market is forecasted to grow by USD 129.7 million during 2024-2029, accelerating at a CAGR of 3% during the forecast period. The report on the heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases and heart failures, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for heart transplantation.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 2.8% |
| CAGR | 3% |
| Incremental Value | $129.7 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's heart transplantation therapeutics market is segmented as below:
By Drug Class
- Immunosuppressants
- Anti-infectives
- Analgesics
- Others
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Type
- Left ventricular assist device (LVAD)
- Heart transplantation
- Implantable cardiac defibrillator (ICD)
- Extracorporeal membrane oxygenation (ECMO)
By Indication
- Ischemic heart disease (IHD)
- Dilated cardiomyopathy (DCM)
- Valvular heart disease (VHD)
- Hypertrophic cardiomyopathy (HCM)
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing international collaborations for heart transplantation as one of the prime reasons driving the heart transplantation therapeutics market growth during the next few years. Also, advent of techniques for heart transplantation and growing awareness and accessibility regarding heart transplantation will lead to sizable demand in the market.
The report on the heart transplantation therapeutics market covers the following areas:
- Heart Transplantation Therapeutics Market sizing
- Heart Transplantation Therapeutics Market forecast
- Heart Transplantation Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heart transplantation therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., DR Reddys Laboratories Ltd., Endo International PLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., LEO Pharma AS, Lupin Ltd., McKesson Corp., Novartis AG, Panacea Biotec Ltd., Pfizer Inc., RPG Enterprises, Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the heart transplantation therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Heart Transplantation Therapeutics Market 2019 - 2023
- Historic Market Size - Data Table on Global Heart Transplantation Therapeutics Market 2019 - 2023 ($ million)
- 5.2 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
- 5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- 5.4 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.5 Indication segment analysis 2019 - 2023
- Historic Market Size - Indication Segment 2019 - 2023 ($ million)
- 5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI in global heart transplantation therapeutics market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Drug Class
- 8.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
- 8.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 8.3 Immunosuppressants - Market size and forecast 2024-2029
- Chart on Immunosuppressants - Market size and forecast 2024-2029 ($ million)
- Data Table on Immunosuppressants - Market size and forecast 2024-2029 ($ million)
- Chart on Immunosuppressants - Year-over-year growth 2024-2029 (%)
- Data Table on Immunosuppressants - Year-over-year growth 2024-2029 (%)
- 8.4 Anti-infectives - Market size and forecast 2024-2029
- Chart on Anti-infectives - Market size and forecast 2024-2029 ($ million)
- Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ million)
- Chart on Anti-infectives - Year-over-year growth 2024-2029 (%)
- Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
- 8.5 Analgesics - Market size and forecast 2024-2029
- Chart on Analgesics - Market size and forecast 2024-2029 ($ million)
- Data Table on Analgesics - Market size and forecast 2024-2029 ($ million)
- Chart on Analgesics - Year-over-year growth 2024-2029 (%)
- Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
- 8.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.7 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
9 Market Segmentation by Distribution Channel
- 9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- 9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 9.3 Hospital pharmacies - Market size and forecast 2024-2029
- Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- 9.4 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- 9.5 Online pharmacies - Market size and forecast 2024-2029
- Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Type
- 10.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 10.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 10.3 Left ventricular assist device (LVAD) - Market size and forecast 2024-2029
- Chart on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million)
- Data Table on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million)
- Chart on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%)
- Data Table on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%)
- 10.4 Heart transplantation - Market size and forecast 2024-2029
- Chart on Heart transplantation - Market size and forecast 2024-2029 ($ million)
- Data Table on Heart transplantation - Market size and forecast 2024-2029 ($ million)
- Chart on Heart transplantation - Year-over-year growth 2024-2029 (%)
- Data Table on Heart transplantation - Year-over-year growth 2024-2029 (%)
- 10.5 Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029
- Chart on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million)
- Data Table on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million)
- Chart on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%)
- Data Table on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%)
- 10.6 Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029
- Chart on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million)
- Data Table on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million)
- Chart on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%)
- Data Table on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%)
- 10.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
11 Market Segmentation by Indication
- 11.1 Market segments
- Chart on Indication - Market share 2024-2029 (%)
- Data Table on Indication - Market share 2024-2029 (%)
- 11.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
- 11.3 Ischemic heart disease (IHD) - Market size and forecast 2024-2029
- Chart on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million)
- Data Table on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million)
- Chart on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%)
- Data Table on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%)
- 11.4 Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029
- Chart on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million)
- Data Table on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million)
- Chart on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%)
- Data Table on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%)
- 11.5 Valvular heart disease (VHD) - Market size and forecast 2024-2029
- Chart on Valvular heart disease (VHD) - Market size and forecast 2024-2029 ($ million)
- Data Table on Valvular heart disease (VHD) - Market size and forecast 2024-2029 ($ million)
- Chart on Valvular heart disease (VHD) - Year-over-year growth 2024-2029 (%)
- Data Table on Valvular heart disease (VHD) - Year-over-year growth 2024-2029 (%)
- 11.6 Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029
- Chart on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029 ($ million)
- Data Table on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029 ($ million)
- Chart on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2024-2029 (%)
- Data Table on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2024-2029 (%)
- 11.7 Market opportunity by Indication
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.10 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 13.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 13.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.13 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 13.14 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.15 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 13.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.1 Market drivers
- 14.2 Market challenges
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- 16.2 Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- 16.5 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
- 16.6 Biocon Ltd.
- Biocon Ltd. - Overview
- Biocon Ltd. - Business segments
- Biocon Ltd. - Key offerings
- Biocon Ltd. - Segment focus
- SWOT
- 16.7 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- 16.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 16.9 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 16.10 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- 16.11 Intas Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT
- 16.12 LEO Pharma AS
- LEO Pharma AS - Overview
- LEO Pharma AS - Product / Service
- LEO Pharma AS - Key offerings
- SWOT
- 16.13 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- 16.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 16.15 Panacea Biotec Ltd.
- Panacea Biotec Ltd. - Overview
- Panacea Biotec Ltd. - Product / Service
- Panacea Biotec Ltd. - Key news
- Panacea Biotec Ltd. - Key offerings
- SWOT
- 16.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 16.17 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
- 16.18 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.5 Data procurement
- 17.6 Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
